Gossamer Bio, Inc. Share Price & Technical Analysis
GOSS · $0.22 (+4.76%)
Healthcare / Biotechnology
$0.22
+4.76%
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phas…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
-50% return in May, -1% avg return in past 3 year May month.
-152% return in 2026, 50% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -28% | -83% | -25% | 33% | -50% | – | – | – | – | – | – | – | -152% |
| 25 | 11% | 20% | -15% | -9% | 10% | 9% | 67% | 25% | 8% | -4% | 32% | -6% | 148% |
| 24 | -11% | 56% | -14% | -42% | -14% | 50% | 0% | 0% | 25% | -10% | -22% | 29% | 46% |
| 23 | 18% | -35% | -24% | 8% | 0% | -14% | 17% | -23% | -27% | -37% | 60% | 13% | -45% |
| 22 | -16% | -6% | -3% | -21% | 3% | 18% | 37% | 24% | -13% | -8% | -23% | -74% | -83% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$76.11M
P/E ratio
—
52W high
$3.87
52W low
$0.16
Volume
1,31,06,569
Beta
2.15
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Gossamer Bio, Inc. share price today?
- Gossamer Bio, Inc. (GOSS) last traded around $0.22 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does GOSS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for GOSS. Download the app for real-time alerts.
- How can I analyze Gossamer Bio, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.